Venture
Lumicell, Inc.
Latest Form D 2025-05-06- CIK 1521898
- State MA
- Biotechnology
- 9 Form D offerings since 2011-06-01
- Total sold
- $331M
- across 9 offerings
- Rounds
- 9
- Form D offerings since 2011-06-01
- Latest round
- $198M
- 2025-05-06 · 021-545378
- Investors
- 64
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-05-06 · $198M
- 2011-06-01$2.7M021-160610
- 2014-01-03$1.6M021-209204
- 2016-05-04$6.8M021-262556
- 2017-10-18$20.7M021-296979
- 2018-12-20$20.4M021-328559
- 2023-07-26$75.8M021-487995
- 2024-03-08$2.3M021-507043
- 2024-07-25$2.7M021-519721
- 2025-05-06$198M021-545378
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($198M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-545378 | First filed2025-05-06 | Latest2025-05-06 | SoughtIndefinite | Sold$198M | Investors64 | Exemptions506(b) |
| 021-519721 | First filed2024-07-25 | Latest2024-07-25 | Sought$12M | Sold$2.7M | Investors11 | Exemptions506(b) |
| 021-507043 | First filed2024-03-08 | Latest2024-03-08 | SoughtIndefinite | Sold$2.3M | Investors6 | Exemptions506(b) |
| 021-487995 | First filed2023-07-26 | Latest2023-07-26 | Sought$110M | Sold$75.8M | Investors47 | Exemptions506(b) |
| 021-328559 | First filed2018-12-20 | Latest2018-12-20 | Sought$35M | Sold$20.4M | Investors25 | Exemptions506(b) |
| 021-296979 | First filed2017-10-18 | Latest2017-10-18 | Sought$26.5M | Sold$20.7M | Investors24 | Exemptions506(b) |
| 021-262556 | First filed2016-05-04 | Latest2016-05-04 | Sought$10M | Sold$6.8M | Investors10 | Exemptions506(b) |
| 021-209204 | First filed2014-01-03 | Latest2014-02-25 | Sought$1.6M | Sold$1.6M | Investors7 | Exemptions506(b) |
| 021-160610 | First filed2011-06-01 | Latest2011-06-01 | Sought$3.9M | Sold$2.7M | Investors4 | Exemptions506 |
Who backs Lumicell, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-05-06
| Name | Relationship |
|---|---|
| Howard Hechler | RelationshipExecutive Officer, Director |
| Jorge Ferrer | RelationshipExecutive Officer |
| Andrey J. Zarur | RelationshipDirector |
| James Alecxih | RelationshipDirector |
| Elon Boms | RelationshipDirector |
| David Furneaux | RelationshipDirector |
| Kevin Krenitsky | RelationshipDirector |
| Carlos Gonzalez | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Network 1 Financial Securities Inc. | CRD13577 | Broker-dealer— | Offerings2 |
| Network Financial Securities Inc. | CRD13577 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2011-06-01
- Latest filing
- 2025-05-06
Who backs Lumicell, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗